mRNA therapies are one of the hottest drug classes today, but scientists need to solve issues of stability, immunogenicity and delivery first. New methods could help. Just as in battle, the timely ...
Meanwhile Moderna, who make one of the mRNA COVID vaccines, had originally been pursuing the development of an HIV vaccine of their own, but repurposed their research in order to make their COVID ...
In 2021, Schief announced results from the IAVI G001 clinical trial, showing that an adjuvanted protein-based version of the priming immunogen (eOD-GT8 60mer) induced the desired B-cell response in 97 ...
How does a COVID-19 mRNA vaccine work? COVID vaccines are now available. Some of the COVID-19 vaccines are mRNA vaccines, but what does this mean? mRNA vaccines are different from traditional ...
PopVax (https://popvax.com) has developed a novel mRNA architecture for immunogen display on virus-like particles (VLPs), a lipid nanoparticle (LNP) delivery platform for mRNA using PopVax ...
But this is the first phase-IIb randomised clinical trial to test the investigational mRNA vaccine in patients. Could Covid vaccine technology crack cancer? Patients taking Keytruda for advanced ...
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines ...
PopVax (https://popvax.com) has developed a novel mRNA architecture for immunogen display on virus-like particles (VLPs), a lipid nanoparticle (LNP) delivery platform for mRNA using PopVax ...